Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 106
Filtrar
Mais filtros

Base de dados
País/Região como assunto
Tipo de documento
Assunto da revista
País de afiliação
Intervalo de ano de publicação
1.
Arch Mal Coeur Vaiss ; 83 Spec No 3: 51-6, 1990 Sep.
Artigo em Francês | MEDLINE | ID: mdl-2147835

RESUMO

The aim of this study was to assess the effects of enoximone on the right ventricle and pulmonary hypertension in 10 patients (53 to 84 years) with chronic obstructive airway disease resulting in acute or chronic respiratory failure requiring mechanical ventilation in 9 cases. These effects were compared with those of dobutamine. All patients were in sinus rhythm and 6 had signs of right ventricular failure. Haemodynamic and 2D echocardiographic (study of left and right ventricular function) measurements were made under basal conditions (TB1), with 10 micrograms/kg/mn of dobutamine (TDob), again under basal conditions (TB2) three hours after the end of the dobutamine infusion, and then 30 minutes after an intravenous bolus (1 mg/kg) of enoximone (TE1) relayed by an infusion of 10 micrograms/kg/mn at 3 hours (TE2) and at 12 hours (TE3). The results (x +/- SD) were studied by a 2 factor variance analysis and compared by Student's test with Dunnett's correction. Cardiac index increased similarly by about 45% with enoximone (2.8 +/- 0.8 vs 4.1 +/- 1 l/min/m2; p less than 0.001 at TE2) and dobutamine, although the heart rate did not change significantly. Systemic arterial resistance fell significantly with enoximone (31.3 +/- 11 vs 21.3 +/- 6.8 IU; p less than 0.05 at TE2) but mean arterial pressures were unchanged; mean pulmonary artery pressures decreased from TE1 to TE3 (27.6 +/- 6.9 vs 22.6 +/- 6.3 mmHg; p less than 0.05 at TE2) mainly because pulmonary artery diastolic pressures decreased from TE1 to TE3 (20.1 +/- 4 vs 11.1 +/- 5.2 mmHg; p less than 0.05 at TE3).(ABSTRACT TRUNCATED AT 250 WORDS)


Assuntos
Cardiotônicos/farmacologia , Hipertensão Pulmonar/tratamento farmacológico , Imidazóis/farmacologia , Pneumopatias Obstrutivas/complicações , Insuficiência Respiratória/tratamento farmacológico , Idoso , Idoso de 80 Anos ou mais , Cardiotônicos/uso terapêutico , Dobutamina/farmacologia , Dobutamina/uso terapêutico , Enoximona , Feminino , Ventrículos do Coração/efeitos dos fármacos , Humanos , Hipertensão Pulmonar/etiologia , Imidazóis/uso terapêutico , Masculino , Pessoa de Meia-Idade , Circulação Pulmonar/efeitos dos fármacos , Insuficiência Respiratória/etiologia , Vasodilatação/efeitos dos fármacos
2.
Ann Pathol ; 3(4): 307-12, 1983 Dec.
Artigo em Francês | MEDLINE | ID: mdl-6667287

RESUMO

The case of a 23-year old transsexual male who developed a lethal lung disease 48 hr after a 1 l subcutaneous silicone fluid injection is reported. Histologic examination showed optically empty oil red O negative vacuoles in several specimens, and particularly in the lungs; refractile particles of silicium were also found. We identified the material as silicium, and evaluated its quantity in tissues by atomic absorption and spectrometric and toxicological analysis. Experimental studies and rare human accidents suggest that silicone fluid is transported by migrating phagocytes, thereby explaining lymph node, spleen, liver, adrenal and lung deposits. In our patient's report, we added gradual blood contamination to explain the progressive development of respiratory failure with the severity of the respiratory disorder linked to the massive dose injected. Massive silicone blood embolization could be excluded because of the interval between the injection and emergence of the first clinical signs.


Assuntos
Embolia Pulmonar/induzido quimicamente , Silicones/efeitos adversos , Adulto , Embolia Aérea/patologia , Quadril , Humanos , Injeções Subcutâneas , Pulmão/ultraestrutura , Masculino , Embolia Pulmonar/patologia , Silicones/administração & dosagem , Distribuição Tecidual , Transexualidade
3.
Ann Cardiol Angeiol (Paris) ; 33(3): 153-8, 1984 Apr.
Artigo em Francês | MEDLINE | ID: mdl-6732146

RESUMO

The aim of this study, based on the electrocardiographic analysis of 42 patients in status asthmaticus, is to define the basic criteria which may be used as a basis for electrocardiographic differential diagnosis. The following ECG changes were observed: the pulmonary "p" wave is common, sometimes with exaggerated amplitude in peripheral leads, however, in the precordial leads, the voltage of the "p" wave is reduced; most cases have a vertical heart with clockwise rotation and mild right axis deviation, S1 Q2 Q3 and the transitional zone displaced to the left. Ten cases also had a S1 S2 S3 appearance and three cases showed Q1 Q2 Q3, simulating myocardial infarction; there is poor progression of the R wave in the precordial leads and marked persistence of the S wave in the left precordial leads. In some cases, a QS complex dominates the right precordial leads. A variation in the amplitude of the QRS with the respiratory rhythm is often seen in V1 and V2; ventricular repolarization shows a lowered J point with an upward oblique ST segment in the peripheral leads. However, in the precordial leads, the repolarization is normal except for three cases which presented a frank hypokalaemia. The mechanism of these electrocardiographic changes appears to depend on the vertical position of the heart caused by over expansion of the lungs and pulmonary arterial hypertension. The elements of the electrocardiographic differential diagnosis with myocardial infarction and pulmonary embolism are discussed.


Assuntos
Asma/fisiopatologia , Eletrocardiografia , Doença Cardiopulmonar/diagnóstico , Adolescente , Adulto , Idoso , Asma/diagnóstico , Diagnóstico Diferencial , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Infarto do Miocárdio/diagnóstico , Embolia Pulmonar/diagnóstico
4.
Presse Med ; 25(31): 1411-4, 1996 Oct 19.
Artigo em Francês | MEDLINE | ID: mdl-8958866

RESUMO

On admission to intensive care units, the acid-base profile in acute severe asthma appears to be more diverse than previously. Especially a mixed or less frequently metabolic acidosis is eventually observed, which is not always caused by elevated lactate. On the other hand, hyperlactatemia is actually rather common, not necessarily accompanied by acidosis. This finding is as a rule related to massive doses of beta 2 adrenergic agents given parenterally: subsequent elevated lactate is in no way a marker of cellular hypoxia and has no pejorative meaning in this event. Hypercapnia with severe respiratory acidosis implies less and less mechanical ventilation; however, when mandatory, it has to be carried out using permissive hypercapnia, giving more favorable outcome while lowering side-effects.


Assuntos
Acidose/etiologia , Asma/complicações , Acidose/classificação , Acidose/metabolismo , Acidose Respiratória/etiologia , Acidose Respiratória/fisiopatologia , Doença Aguda , Asma/metabolismo , Humanos
5.
Ann Fr Anesth Reanim ; 2(1): 44-6, 1983.
Artigo em Francês | MEDLINE | ID: mdl-6625237

RESUMO

Three cases of acute gangrenous acalculous cholecystitis, revealed by a postoperative septic shock, are reported. Clinical examination was negative and the surgery gave the diagnosis. Infection with biliary stasis and ischaemia accounts for this pathological entity. The very serious prognosis of this condition can only be reversed by cholecystectomy.


Assuntos
Colecistite/diagnóstico , Choque Séptico/etiologia , Doença Aguda , Adulto , Colecistite/fisiopatologia , Colecistite/cirurgia , Feminino , Gangrena , Humanos , Masculino , Pessoa de Meia-Idade , Complicações Pós-Operatórias
6.
Rev Mal Respir ; 2 Suppl 1: S61-7, 1985.
Artigo em Francês | MEDLINE | ID: mdl-2870549

RESUMO

The objectives of this study, in which Almitrine bismesylate was administered for one year in chronic bronchitics with obstructive hypoxia, were to assess its clinical and gasometric efficacy and its clinical, laboratory, spirometric and electrocardiac acceptability. The blood gas results show a significant rise in PaO2 (p less than 0.001) rising by 5.5 mmHg after 6 months (T6) and by 6.0 mmHg after 12 months (T12) in comparison with the value at the study's onset. The PaCO2 fell by 3.3 mmHg at T6 and 2.7 mmHg at T12 (p less than 0.001). The dyspnoea of the patient, scored by the doctor on a scale of severity from 0 to 5 was situated on a mean of 3.3 points at the beginning of the study. It was significantly reduced by 0.8 points at T6 and by 0.9 points at T12 (p less than 0.001). The percentage of patients hospitalised during the course of the study fell significantly in comparison with the previous year, from 68% to 49% (p less than 0.001). The improvement in clinical status and in blood gases bore no relation to changes in respiratory function. The clinical acceptability of the product was good; few side effects were observed and the respiratory, digestive and neurological problems were often pre-existing. They only led to cessation of treatment in three cases. The electrocardiogram was unchanged. The laboratory investigations was unchanged, with the exception of a fall in red blood cells in relation to the correction of the hypoxaemia in polycythaemic patients.


Assuntos
Bronquite/tratamento farmacológico , Estimulantes do Sistema Nervoso Central/uso terapêutico , Piperazinas/uso terapêutico , Almitrina , Bronquite/fisiopatologia , Doença Crônica , Tolerância a Medicamentos , Dispneia/tratamento farmacológico , Feminino , Seguimentos , Humanos , Masculino , Troca Gasosa Pulmonar , Testes de Função Respiratória
7.
Presse Med ; 12(4): 213-6, 1983 Jan 29.
Artigo em Francês | MEDLINE | ID: mdl-6220370

RESUMO

Plasma fibronectin (FNp) concentrations were measured in 63 patients with acute respiratory failure and 28 patients with circulatory failure, using Laurell's electroimmunoassay method. Measurements were made in the acute phase and repeated in the course of the disease. The mean FNp concentration in 20 controls was 262 +/- 59 mg/l. FNp values were normal in the acute phase of chronic obstructive pulmonary disease and in cardiogenic pulmonary oedema. In contrast, they were significantly decreased in adult respiratory distress syndrome and in acute pneumonia, as well as in acute circulatory failure, notably from septic shock. FNp values were also considerably reduced in patients with severe disseminated intravascular coagulation syndrome. Clinical improvement was accompanied by a return to normal of FNp concentrations. The mortality rate was greater in patients with low FNp values than in those with normal values.


Assuntos
Fibronectinas/sangue , Insuficiência Respiratória/sangue , Choque/sangue , Doença Aguda , Adulto , Idoso , Fatores de Coagulação Sanguínea/análise , Coagulação Intravascular Disseminada/sangue , Humanos , Imunodifusão , Pessoa de Meia-Idade , Prognóstico , Síndrome do Desconforto Respiratório/sangue , Choque Séptico/sangue
8.
Bull Acad Natl Med ; 178(2): 213-23; discussion 223-5, 1994 Feb.
Artigo em Francês | MEDLINE | ID: mdl-8039003

RESUMO

This study is dedicated to the epidemiology of pneumothoraces (217 cases) during the last 8 years in an Intensive Care Department where most patients were admitted for respiratory diseases. Cases resulting from road-injury or surgery were excluded. Spontaneous pneumothoraces accounted for 61.8% of the cases. Among them, the most current etiology was idiopathic pneumothorax owing to small subpleural blebs, rarely leading to tension pneumothorax or hemapneumothorax. Other causes were pulmonary emphysema, more often than chronic obstructive pulmonary disease or acute asthma, active pulmonary tuberculosis, and acute pneumonia (especially AIDS-related Pneumocystis Carinii pneumonia). Among the iatrogenic pneumothoraces (38.2%), three sources accounted for 79 out of the 83 cases observed: drainage of pleural effusions, subclavian vein catheterization, mechanical ventilation of patients suffering from refractory hypoxemia or evincing very high bronchial resistances, therefore requiring special ventilatory techniques, such as positive end-expiratory pressure. Whereas pneumothoraces induced by pleural or venous access were not by themselves detrimental, the course of pneumothorax associated with ventilatory support was as a rule unfavourable, death being due to the pneumothorax per se in about fifty per cent of the cases. Various techniques, unequally efficient, were suggested to avoid or control this ominous side-effect of mechanical ventilation, which remains a serious problem.


Assuntos
Doença Iatrogênica , Pneumotórax/epidemiologia , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Feminino , França/epidemiologia , Humanos , Masculino , Pessoa de Meia-Idade , Unidades de Cuidados Respiratórios , Estudos Retrospectivos
9.
Bull Acad Natl Med ; 179(8): 1671-88, 1995 Nov.
Artigo em Francês | MEDLINE | ID: mdl-8717184

RESUMO

This review is going on to emphasize recent advances of the pathophysiology of septic shock (SS) which goes-between the systemic inflammatory response syndrome (SIRS) and the multisystem organ failure (MOF). By several recent studies, our knowledge of the cellular and molecular pathophysiology of the SS has dramatically increased. Bacterial products, immunocompetent cells, soluble mediators, and cell-cell interactions between blood cells and endothelium have been reviewed. The metabolic disorders following SS can also be observed during SIRS. Still further, these abnormalities do not accurately predict prognosis, except some of them. A wealth of pre-clinical data suggests the efficacy and potentially useful therapeutic strategies like specific immunotherapy (anti-endotoxin, antimediators). Discrepancies between animals models and unexpected and disappointing clinical trial results during SS are discussed. Blocking simultaneously the hole metabolic patterns of SS which is a complex, multisystem, and multifactorial pathologic process seems to be a utopian situation. Furthermore SS occuring more frequently as a complication of nosocomial infection, the high cost of such a novel therapeutic strategy has to be taken into account.


Assuntos
Choque Séptico/fisiopatologia , Adolescente , Animais , Adesão Celular/imunologia , Cricetinae , Cobaias , Humanos , Inflamação/imunologia , Mediadores da Inflamação/imunologia , Choque Séptico/imunologia
10.
Rev Prat ; 40(22): 2055-9, 1990 Oct 01.
Artigo em Francês | MEDLINE | ID: mdl-2237204

RESUMO

Metabolic alkalosis (MA) only occurs after bicarbonate administration if given quickly and massively, or in the presence of renal failure. Most cases of MA are caused by a loss of hydrogen ions. This paper reviews the common causes (gastric aspiration, chronic diuretic therapy) and updates the list of drugs which may lead to this complication. Rare causes (such as hyper mineralo-corticoid secretion) should be suspected in patients with MA unresponsive to usual doses of potassium chloride. Hydrochloric acid infusions are reserved for very special cases.


Assuntos
Alcalose/metabolismo , Alcalose/diagnóstico , Alcalose/tratamento farmacológico , Alcalose/fisiopatologia , Humanos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA